The role of the tumor microenvironment in leukemias and lymphomas is well-established, yet the intricacies of how the malignant cells regulate and influence their non-malignant counterparts remain elusive. For example, chronic lymphocytic leukemia is an expansion of malignant CD5+CD19+ B cells, yet the non-malignant T cells play just as large of a role in disease presentation and etiology. Herein, we review the dynamic tumor cell to lymphoid repertoire interactions found in two Non-Hodgkin’s lymphoma subtypes: chronic lymphocytic leukemia and angioimmunoblastic T-cell lymphoma. We aim to highlight the pivot work done in the murine models which recapitulate these diseases and explore the insights that can be gained from studying the immuno-o...
Mouse models of human disease are valuable tools for studying pathogenesis and for evaluating novel ...
<p>Adult T cell Leukemia/Lymphoma (ATLL) is a mature T cell malignancy associated with Human T cell ...
To mount an effective anti-tumor immune response capable of controlling or eliminating disease, suff...
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in western world. This disease,...
Chronic lymphocytic leukemia (CLL) cells survive longer in vivo than in vitro, suggesting that the t...
Chronic lymphocytic leukaemia (CLL) cells require microenvironmental support for their proliferation...
Murine models serve as an effective way to mimic the in vivo tumor microenvironmental interactions t...
Dozens of murine models of indolent and aggressive B-cell lymphomas have been generated to-date. The...
Chronic lymphocytic leukemia (CLL) can be divided into prognostically distinct subsets with stereoty...
Chronic lymphocytic leukaemia (CLL) is a malignancy ofbmature B lymphocytes, characterised bybthe ac...
<p>Adult T cell Leukemia/Lymphoma (ATLL) is a mature T cell malignancy associated with Human T cell ...
International audienceHuman B-cell lymphomas, the fourth most common hematologic malignancy, are cur...
<p>Adult T cell Leukemia/Lymphoma (ATLL) is a mature T cell malignancy associated with Human T cell ...
PhDChronic lymphocytic leukaemia (CLL) is the most common adult leukaemia, and despite recent introd...
In chronic lymphocytic leukemia (CLL), increasing knowledge of the biology of the tumor cells has le...
Mouse models of human disease are valuable tools for studying pathogenesis and for evaluating novel ...
<p>Adult T cell Leukemia/Lymphoma (ATLL) is a mature T cell malignancy associated with Human T cell ...
To mount an effective anti-tumor immune response capable of controlling or eliminating disease, suff...
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in western world. This disease,...
Chronic lymphocytic leukemia (CLL) cells survive longer in vivo than in vitro, suggesting that the t...
Chronic lymphocytic leukaemia (CLL) cells require microenvironmental support for their proliferation...
Murine models serve as an effective way to mimic the in vivo tumor microenvironmental interactions t...
Dozens of murine models of indolent and aggressive B-cell lymphomas have been generated to-date. The...
Chronic lymphocytic leukemia (CLL) can be divided into prognostically distinct subsets with stereoty...
Chronic lymphocytic leukaemia (CLL) is a malignancy ofbmature B lymphocytes, characterised bybthe ac...
<p>Adult T cell Leukemia/Lymphoma (ATLL) is a mature T cell malignancy associated with Human T cell ...
International audienceHuman B-cell lymphomas, the fourth most common hematologic malignancy, are cur...
<p>Adult T cell Leukemia/Lymphoma (ATLL) is a mature T cell malignancy associated with Human T cell ...
PhDChronic lymphocytic leukaemia (CLL) is the most common adult leukaemia, and despite recent introd...
In chronic lymphocytic leukemia (CLL), increasing knowledge of the biology of the tumor cells has le...
Mouse models of human disease are valuable tools for studying pathogenesis and for evaluating novel ...
<p>Adult T cell Leukemia/Lymphoma (ATLL) is a mature T cell malignancy associated with Human T cell ...
To mount an effective anti-tumor immune response capable of controlling or eliminating disease, suff...